INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $474,300 | -22.5% | 15,000 | 0.0% | 0.01% | -30.8% |
| Q2 2023 | $611,700 | +9.4% | 15,000 | 0.0% | 0.01% | +18.2% |
| Q1 2023 | $559,050 | +60.2% | 15,000 | +50.0% | 0.01% | +83.3% |
| Q4 2022 | $348,900 | -37.7% | 10,000 | 0.0% | 0.01% | -45.5% |
| Q3 2022 | $560,000 | +8.1% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $518,000 | -28.7% | 10,000 | 0.0% | 0.01% | -26.7% |
| Q1 2022 | $727,000 | -38.5% | 10,000 | 0.0% | 0.02% | -42.3% |
| Q4 2021 | $1,182,000 | -11.9% | 10,000 | 0.0% | 0.03% | -16.1% |
| Q3 2021 | $1,342,000 | -17.1% | 10,000 | 0.0% | 0.03% | -6.1% |
| Q2 2021 | $1,619,000 | +101.6% | 10,000 | 0.0% | 0.03% | +83.3% |
| Q1 2021 | $803,000 | +47.6% | 10,000 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $544,000 | +173.4% | 10,000 | 0.0% | 0.02% | +125.0% |
| Q3 2020 | $199,000 | -5.2% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $210,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |